HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

SOLACI CACI 2017 | Prevention of valvular thrombosis: antiaggregation or anticoagulation?

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr....

SOLACI CACI 2017 | TAVI: Clinical Evidence of long term durability of prosthetic valves

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dra. Carla...

SOLACI CACI 2017 | Clinical evidence of TAVR in intermediate risk patients: Lessons from clinical trials

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Andreas...

SOLACI CACI | TAVI: Evidencia para pacientes de riesgo intermedio

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Oscar...

SOLACI CACI 2017 | Role of embolic protection during Transcatheter Aortic valve replacement

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Samir...

SOLACI CACI 2017 | When and how to interving patients with CAD undergoing TAVI

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Fabio...

SOLACI CACI 2017 | Role of general anesthesia compare to conscious sedation during TAVR

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress.  Check the presentation of Dr....

Dual Antiplatelet in TAVR: Is Single Better?

Courtesy of Dr. Agustín Vecchia. As TAVR is expanded to lower risk patients, complications become more relevant. As regards...